News

All current DZIF news can be found here.

Several mustard-coloured, spherical bacteria in the middle of much smaller blue-coloured blood cells.

Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus in the nasal microbiome

The novel active agent HY-133, which was developed by HYpharm and prepared for clinical trials in collaboration with the German Center for Infection Research (DZIF) and universities in Tübingen

Four schematically depicted people in purple, blue, yellow and pink outerwear against a green background with a grey-shaded group of people.

World Hepatitis Day: a call for increased international commitment in the fight against hepatitis

The motto of this year's World Hepatitis Day, proclaimed annually on 28 July by the World Health Organisation (WHO), is “It's time to act". Hundreds of millions of people worldwide are affected by

Prof. Percy Knolle and first author Dr Miriam Bosch in front of a fluorescence microscope in the lab

Hepatitis B: Liver cells switch off the immune response

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus-infected cells but are inactive. An international team led by Percy Knolle and Ulrike Protzer at the

A world map shows the distribution of COVID-19 cases, represented by red dots and circles of different sizes. The largest concentrations are visible in North America, Europe and Asia. In the other continents, such as South America, Africa and Australia, red dots can also be seen, but in lower density. The map has a dark background and the continents are shown in black with white outlines and labelling.

Learning from the COVID pandemic: on the effectiveness of non-pharmaceutical interventions against pathogens

In the years of the COVID-19 pandemic, the effectiveness of government-ordered measures to contain the pandemic, such as regular testing and the wearing of medical masks, was repeatedly called into

A group of ten people are standing outside in front of a building. The background shows a one-storey building with a tin roof and plants.

UNITE4TB completes recruitment for DECISION trial

UNITE4TB—an international public-private partnership aiming to accelerate the development of innovative tuberculosis treatments—has announced the successful completion of participant recruitment for

A tuning fork is struck in contact with a foot to test sensitivity in the diagnosis of neuropathy.

New biomarker for predicting side effects of multidrug-resistant tuberculosis therapy

Treatment with Linezolid, an antibiotic that is used against multi-resistant tuberculosis bacteria, leads to adverse drug reactions in around a quarter of patients, including certain nerve disorders

The picture shows the Infektiopod team of three standing in front of a harbour landscape in Hamburg. All three people are smiling at the camera. On the left is Annette Hennigs with a blue sleeveless top, in the centre is Elena Terhalle with curly, shoulder-length hair and a black T-shirt, and on the right is Till Koch with short hair, a blue polo shirt and tattooed arms. In the background you can see cranes and buildings on the waterfront.

DZIF promotes podcast on infectious diseases

"Infektiopod", a podcast in German language that has been providing information on human infectious diseases since 2019, is now being funded by the German Center for Infection Research (DZIF). The

The INCATE team at the AMR conference in Basel 2024

INCATE receives Lighthouse Award 2024 from Swiss National Science Foundation

INCATE, the INCubator for Antimicrobial Therapies in Europe co-founded by the German Center for Infection Research, has been honoured with the 2024 Lighthouse Award for outstanding Transfer of

Prof. Dr Marc Huebner and Prof. Dr Achim Hoerauf

Award for drug research on river blindness and elephantiasis

DZIF professors Marc Hübner and Achim Hörauf are part of the international team that has now been awarded the Horizon Prize 2024 by the Royal Society of Chemistry.

New perspectives for patients: National Strategy for Gene- and Cell-based Therapies

Around 150 experts from various stakeholder groups—including a number of scientists from the network of the German Center for Infection Research (DZIF)—have developed a roadmap for improving